Internal Medicine, Endocrinology, Diabetes, & Metabolism · Lexington, KY
NPI
1053773465
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2195 Harrodsburg Rd Ste 125
Lexington, KY, 40504
Phone (859) 323-2232
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
559 services
Medicare patients, 2024
119
Average age 69
Drug cost, 2024
$1.6M
3,100 prescriptions
Company payments, 2025
$115
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kyle Rosenstein was code 99214 (office e&m - established), 136 times for 70 patients. In total Kyle Rosenstein billed 559 services in 13 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 136 | 70 | $82.48 | $11K |
| 83036 Blood Count | Office | 90 | 47 | $9.41 | $847 |
| 36415 Venipuncture Blood Collection | Office | 80 | 61 | $8.65 | $692 |
| 95251 Test - Miscellaneous | Office | 54 | 26 | $24.87 | $1,343 |
| 82947 Clinical Chemistry | Office | 44 | 26 | $3.76 | $166 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 41 | 38 | $12.64 | $518 |
| 99213 Office E&M - Established | Office | 33 | 26 | $59.67 | $1,969 |
| 99204 Office E&M - New | Office | 32 | 32 | $108.92 | $3,486 |
| 76536 Ultrasound - Nonspecific | Office | 24 | 18 | $78.66 | $1,888 |
| 99203 Office E&M - New | Office | 14 | 14 | $79.73 | $1,116 |
By year: 2022 $5,782 for 83 services; 2023 $19K for 405 services; 2024 $24K for 559 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 90 | 47 | $9.41 | $847 |
| 36415 Venipuncture Blood Collection | 80 | 61 | $8.65 | $692 |
| 82947 Clinical Chemistry | 44 | 26 | $3.76 | $166 |
Medicare prescription drug claims, 2024
In 2024, the drug Kyle Rosenstein prescribed most often to Medicare patients was Levothyroxine Sodium, with 202 prescriptions and refills. In total Kyle Rosenstein wrote 3,100 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 202 | 461 | 69 | $2,404 |
| Ozempic Semaglutide | 185 | 306 | 43 | $289K |
| Jardiance Empagliflozin | 160 | 347 | 47 | $202K |
| Metformin Hcl Er Metformin Hcl | 124 | 311 | 40 | $1,291 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 124 | 214 | 45 | $18K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 123 | 260 | 49 | $12K |
| Atorvastatin Calcium Generic | 122 | 330 | 38 | $845 |
| Mounjaro Tirzepatide | 113 | 140 | 31 | $147K |
| Tresiba Flextouch U-100 Insulin Degludec | 84 | 142 | 28 | $67K |
| Metformin Hcl Generic | 83 | 219 | 28 | $396 |
| Tresiba Flextouch U-200 Insulin Degludec | 76 | 136 | 23 | $126K |
| Novolog Flexpen Insulin Aspart | 75 | 150 | 29 | $27K |
| Ultra-Fine Micro Pen Needle Pen Needle, Diabetic | 72 | 153 | 26 | $9,498 |
| Trulicity Dulaglutide | 71 | 111 | 17 | $105K |
| Ezetimibe Generic | 66 | 140 | 19 | $1,035 |
Brand drugs: 1,787 claims; generic drugs: 953 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kyle Rosenstein $115 ($115 in general payments such as food, travel and fees) from 5 companies. The largest payer was Beta Bionics, Inc. with $38.71.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.